0000899243-22-039212.txt : 20221222
0000899243-22-039212.hdr.sgml : 20221222
20221222163209
ACCESSION NUMBER: 0000899243-22-039212
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221221
FILED AS OF DATE: 20221222
DATE AS OF CHANGE: 20221222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Karlin Dan
CENTRAL INDEX KEY: 0001897618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40360
FILM NUMBER: 221482342
MAIL ADDRESS:
STREET 1: C/O MIND MEDICINE INC.
STREET 2: ONE WORLD TRADE CENTER, SUITE 8500
CITY: NEW YORK
STATE: NY
ZIP: 10007
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mind Medicine (MindMed) Inc.
CENTRAL INDEX KEY: 0001813814
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
BUSINESS PHONE: (212) 220-6633
MAIL ADDRESS:
STREET 1: 1166 ALBERNI STEET
STREET 2: SUITE 1604
CITY: VANCOUVER
STATE: A1
ZIP: V6E 3Z3
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-12-21
0
0001813814
Mind Medicine (MindMed) Inc.
MNMD
0001897618
Karlin Dan
C/O MIND MEDICINE (MINDMED), INC.
ONE WORLD TRADE CENTER, SUITE 8500
NEW YORK
NY
10007
0
1
0
0
Chief Medical Officer
Common Shares
2022-12-21
4
S
0
1211
2.69
D
264082
D
Common Shares sold to satisfy withholding tax obligations upon the delivery of Common Shares for restricted stock units that vested on November 24, 2022 and November 26, 2022, pursuant to sell-to-cover elections.
The reported price is a weighted average sales price. This represents the price in United States Dollars using the conversion rate on December 21, 2022. These shares were sold in multiple transactions on December 21, 2022 at prices ranging from $3.65 to $3.67 CAD Dollars. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Carrie Liao, Attorney-in-Fact
2022-12-22